Bio-Rad Laboratories BIO
NYSE BIO
$382.40 +3.37 (+0.89%)
As of: Sep 17, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Property, Plant & Equipment (Net) Growth (3y) (2012 - 2026)

Analysis

Bio-Rad Laboratories (BIO) Property, Plant & Equipment (Net) Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 4.99%
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 11.73%
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 20.79%
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -11.34%
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -2.41%
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 0.82%
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 0.25%
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -6.14%
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -8.91%
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 10.96%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.25%
Mar 31, 2026 1.37%
Dec 31, 2025 2.69%
Sep 30, 2025 5.42%
Jun 30, 2025 5.26%
Mar 31, 2025 2.85%
Dec 31, 2024 1.06%
Sep 30, 2024 4.59%
Jun 30, 2024 3.46%
Mar 31, 2024 2.67%
Dec 31, 2023 2.49%
Sep 30, 2023 2.07%
Jun 30, 2023 2.21%
Mar 31, 2023 1.37%
Dec 31, 2022 -0.05%
Sep 30, 2022 -2.39%
Jun 30, 2022 -1.90%
Mar 31, 2022 -1.15%
Dec 31, 2021 0.19%
Sep 30, 2021 -0.53%